Laboratory Monitoring After Short-Course Ceftriaxone Therapy
General Monitoring Recommendations
- The Infectious Diseases Society of America guidelines recommend that laboratory monitoring for ceftriaxone should be based on the duration of therapy, patient risk factors, and baseline laboratory values 1
- For short courses of ceftriaxone (≤3 days), routine monitoring of liver function tests and renal function is generally not necessary in patients with normal baseline values 1
- The 2018 Infectious Diseases Society of America guidelines indicate that for shorter courses of ceftriaxone, it may not be necessary to monitor liver function tests and/or renal function 1
Monitoring Based on Duration
- For standard short-course therapy (≤3 days) in patients with normal baseline values, no routine laboratory monitoring is required 1
Specific Laboratory Tests to Consider
- Renal function tests, such as BUN and creatinine, may be considered in patients with pre-existing renal impairment, as recommended by the Infectious Diseases Society of America 1